These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12703677)

  • 1. Pathophysiology and management of neurocardiogenic syncope.
    Nair N; Padder FA; Kantharia BK
    Am J Manag Care; 2003 Apr; 9(4):327-34; quiz 335-6. PubMed ID: 12703677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical therapy of neurocardiogenic syncope.
    Cadman CS
    Cardiol Clin; 2001 May; 19(2):203-13, v. PubMed ID: 11407106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy for the management of vasovagal syncope.
    Bloomfield DM
    Drugs Aging; 2002; 19(3):179-202. PubMed ID: 12027777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharma-clinics. How I treat vasovagal syncope].
    Kulbertus H; Melon P
    Rev Med Liege; 1999 Jun; 54(6):510-3. PubMed ID: 10446518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of vasovagal syncope.
    Parry SW; Kenny RA
    QJM; 1999 Dec; 92(12):697-705. PubMed ID: 10581332
    [No Abstract]   [Full Text] [Related]  

  • 6. Syncope: pathophysiology, diagnosis, and pharmacotherapy.
    Lazarus JC; Mauro VF
    Ann Pharmacother; 1996 Sep; 30(9):994-1005. PubMed ID: 8876862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of vasovagal syncope.
    Atiga WL; Rowe P; Calkins H
    J Cardiovasc Electrophysiol; 1999 Jun; 10(6):874-86. PubMed ID: 10376927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocardiogenic syncope: latest pharmacological therapies.
    Chen LY; Shen WK
    Expert Opin Pharmacother; 2006 Jun; 7(9):1151-62. PubMed ID: 16732702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical practice. Neurocardiogenic syncope.
    Grubb BP
    N Engl J Med; 2005 Mar; 352(10):1004-10. PubMed ID: 15758011
    [No Abstract]   [Full Text] [Related]  

  • 10. [Syncope - a systematic overview of classification, pathogenesis, diagnosis and management].
    Hilz MJ; Marthol H; Neundörfer B
    Fortschr Neurol Psychiatr; 2002 Feb; 70(2):95-107. PubMed ID: 11823926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocardiogenic syncope in children : current concepts in diagnosis and management.
    Massin M
    Paediatr Drugs; 2003; 5(5):327-34. PubMed ID: 12716219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurally mediated syncopal syndromes: pathophysiological concepts and clinical evaluation.
    Benditt DG
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 2):572-84. PubMed ID: 9058856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in plasma epinephrine concentration and in heart rate during head-up tilt testing in patients with neurocardiogenic syncope: correlation with successful therapy with beta-receptor antagonists.
    Klingenheben T; Kalusche D; Li YG; Schöpperl M; Hohnloser SH
    J Cardiovasc Electrophysiol; 1996 Sep; 7(9):802-8. PubMed ID: 8884509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysautonomia and neurocardiogenic syncope.
    McLeod KA
    Curr Opin Cardiol; 2001 Mar; 16(2):92-6. PubMed ID: 11224639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods other than tilt testing for diagnosing neurocardiogenic (neurally mediated) syncope.
    Brignole M; Menozzi C
    Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 2):795-800. PubMed ID: 9080512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of propantheline bromide in neurocardiogenic syncope: pharmacodynamic implications.
    Yu JC; Sung RJ
    Cardiovasc Drugs Ther; 1997 Jan; 10(6):687-92. PubMed ID: 9110111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of vasovagal syncope and dysautonomia.
    Sealey B; Lui K
    AACN Clin Issues; 2004; 15(3):462-77. PubMed ID: 15475818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of pacing for the management of neurally mediated syncope: carotid sinus syndrome and vasovagal syncope.
    Maloney JD; Jaeger FJ; Rizo-Patron C; Zhu DW
    Am Heart J; 1994 Apr; 127(4 Pt 2):1030-7. PubMed ID: 8160577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of recurrent neurocardiogenic syncope with cardiac inhibitors with ipratropium bromide].
    Friederich HC; Michaelsen J; Hesse C; Schellberg D; Schwab M; Herzog W
    Z Kardiol; 2004 Jun; 93(6):479-85. PubMed ID: 15252742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.
    Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barbone C; Barsotti A
    J Am Coll Cardiol; 1999 Apr; 33(5):1227-30. PubMed ID: 10193720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.